
Vital Access
Stage
Series B - II | AliveTotal Raised
$7.1MValuation
$0000Last Raised
$1.5M | 11 yrs agoMissing: Vital Access's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Vital Access's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Vital Access Patents
Vital Access has filed 16 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
5/18/2015 | 3/12/2019 | Digestive system, Vascular surgery, Catheters, Surgical procedures and techniques, Medical treatments | Grant |
Application Date | 5/18/2015 |
---|---|
Grant Date | 3/12/2019 |
Title | |
Related Topics | Digestive system, Vascular surgery, Catheters, Surgical procedures and techniques, Medical treatments |
Status | Grant |
Latest Vital Access News
Dec 27, 2022
[Webinar] Vital Access: How Policymakers Can Streamline the Cancer Care Journey January 10th, 1:00 pm - 2:00 pm ET To embed, copy and paste the code into your website or blog: <iframe frameborder="1" height="620" scrolling="auto" src="//www.jdsupra.com/post/contentViewerEmbed.aspx?fid=16ff6cc4-c3f0-43d2-992e-27f7c5ba9f27" style="border: 2px solid #ccc; overflow-x:hidden !important; overflow:hidden;" width="100%"></iframe> January 10th, 2023 Over the past 50+ years, there has been enormous progress in understanding the mechanisms that cause blood cancer. As a result, new and groundbreaking treatments have led to significantly improved blood cancer survival rates. Too often, however, patients encounter roadblocks that prevent them from accessing the best care and, in some cases, benefiting from these medical advances. Numerous factors impact access, but a fragmented insurance system, including a patchwork of federal and state rules and policies, is a major contributor. In a new webinar based on their upcoming report, Vital Access: How Policymakers Can Streamline the Cancer Care Journey, The Leukemia & Lymphoma Society and Manatt Health will share nine key recommendations across five reform pathways for state and federal policymakers to consider as they work toward developing insurance regulations that advance a more equitable system of care. Click here to register for the free program. Each pathway addresses specific deficiencies in current insurance policy frameworks, and each is critical for ensuring a more equitable coverage landscape. The pathways the program will cover include: Pathway 1: Addressing Burdens Posed by Inadequate Network Standards Pathway 2: Eliminating Administrative Red Tape Barring Access to Treatment Pathway 3: Reducing Administrative Hurdles of Seeking Out-of-State Care Pathway 4: Increasing Transparency of Plan Network Composition and Performance Pathway 5: Elevating Patient-Facing Support for Plan Selection and Navigation of Coverage and Treatment Even if you can’t attend the live program on January 10, click here to register for the free webinar now and you’ll receive a link to view the session on demand. Speakers: Lucy Culp, Executive Director, State Government Affairs, The Leukemia & Lymphoma Society J. J. Duncan, Patient Advocate Anne Karl, Partner, Manatt Health Alex Morin, Director, Manatt Health Donna O’Brien, National Advisor, Manatt Health
Vital Access Frequently Asked Questions (FAQ)
Where is Vital Access's headquarters?
Vital Access's headquarters is located at 2302 S Presidents Drive, Salt Lake City.
What is Vital Access's latest funding round?
Vital Access's latest funding round is Series B - II.
How much did Vital Access raise?
Vital Access raised a total of $7.1M.
Who are the investors of Vital Access?
Investors of Vital Access include Medica Partners and Orchestra Medical Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.